| pubmed-article:21612823 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C0026764 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C0022688 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C0039195 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:21612823 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:21612823 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:21612823 | pubmed:dateCreated | 2011-8-15 | lld:pubmed |
| pubmed-article:21612823 | pubmed:abstractText | The interaction between dendritic cells (DCs) and natural killer (NK) cells plays a key role in inducing DC maturation for subsequent T-cell priming. We investigated to generate potent DCs by stimulated with NK cells to induce myeloma-specific cytotoxic T lymphocytes (CTLs). NK cells-stimulated-DCs exhibited high expression of costimulatory molecules and high production of IL-12p70. These DCs induce high potency of Th1 polarization and exhibit a high ability to generate myeloma-specific CTLs responses. These results suggest that functionally potent DCs can be generated by stimulation with NK cells and may provide an effective source of DC-based immunotherapy in multiple myeloma. | lld:pubmed |
| pubmed-article:21612823 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21612823 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21612823 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21612823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21612823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21612823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21612823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21612823 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21612823 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:21612823 | pubmed:issn | 1873-5835 | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:LeeHyun JuHJ | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:LeeJe-JungJJ | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:ChungIk-JooIJ | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:ChoDuckD | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:KimHyeoung-Jo... | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:KimYeo-Kyeoun... | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:KimMi-HyunMH | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:HongCheol... | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:YangDeok-Hwan... | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:AhnJae-SookJS | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:ImChang-MinCM | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:LeeYoun-Kyung... | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:LimMi-SeonMS | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:Nguyen-PhamTh... | lld:pubmed |
| pubmed-article:21612823 | pubmed:author | pubmed-author:NguyenTruc-An... | lld:pubmed |
| pubmed-article:21612823 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:21612823 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21612823 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:21612823 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21612823 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21612823 | pubmed:pagination | 1241-7 | lld:pubmed |
| pubmed-article:21612823 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:meshHeading | pubmed-meshheading:21612823... | lld:pubmed |
| pubmed-article:21612823 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21612823 | pubmed:articleTitle | Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma. | lld:pubmed |
| pubmed-article:21612823 | pubmed:affiliation | Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Jeollanamdo, Hwasun, Republic of Korea. | lld:pubmed |
| pubmed-article:21612823 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21612823 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21612823 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
